Leaflet ELIDEL 1% (10mg / g) cream

Product code:
W57974001
Quantity:
1
Indicated for:
atopic dermatitis
Route of administration:
cutaneous
Substance:
pimecrolimus (immunosuppressant)
ATC
D11AH02 — Dermatologicals | Other dermatological preparations | Other dermatological preparations | Agents for dermatitis, excluding corticosteroids

Precautions:

Avoid live vaccines

Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Pimecrolimus is a medication used for the treatment of mild to moderate atopic dermatitis (eczema). It belongs to the class of calcineurin inhibitors and works by reducing inflammation and the immune response in the skin.

The medication is available as a cream and should be applied topically as directed by your doctor. It is important to avoid long-term use or application on large areas without medical supervision.

Side effects may include local irritation, burning sensation, or itching at the application site. In rare cases, severe adverse effects such as skin infections or allergic reactions may occur.

Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of pimecrolimus.

General data about ELIDEL 1% (10mg / g)

Substance:
pimecrolimus
Date of latest medicines list:
01-11-2015
Product code:
W57974001
Concentration:
10mg / g
Pharmaceutical form:
cream
Quantity:
1
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
NOVARTIS PHARMA GMBH - GERMANIA
Holder:
MEDA PHARMA GMBH & CO.KG - GERMANIA
Number:
6063/2014/02
Shelf life:
2 years-after packing for marketing;after the first opening-12 months

Concentrations available for pimecrolimus

  • 1%
  • 10mg
  • 10mg/g